Revealing the truth of human disease. Protein by protein.
Olink’s PEA technology empowers impactful research across a broad range of human diseases, enabling a deeper understanding of the underlying biology and providing actionable biomarkers to stratify patients and accelerate drug development. This is documented in extensive scientific literature covering all major disease areas, from oncology and neurology to aging and population health.
Aging
Aging is a fundamental biological process with an enormous impact on global healthcare. Understanding how the proteome changes with biological and chronological age is accelerating progress in this rapidly developing field.
Cardiovascular diseases
Proteomics provides important insights into major health issues like coronary artery disease, atrial fibrillation, and heart failure. These studies advance understanding of the underlying pathways and risk factors and how they link to associated comorbidities.
Immunological and inflammatory diseases
Sensitive, accurate measurement of the plethora of immune response proteins that interact with each other, and multiple cell types is essential to better understand the complexity of immune system responses and the changes underlying autoimmune and inflammatory diseases.
Neurological diseases
Blood and cerebrospinal fluid (CSF) proteomics enable a deeper understanding of disease biology, assessment of risk, diagnosis, and monitoring of key neurological conditions such as Alzheimer’s disease, traumatic brain injury, multiple sclerosis, and chronic pain.
Oncology and immuno-oncology
Adding a much-needed layer of resolution to genomic data, proteomic studies are identifying new diagnostic, prognostic, and long-range risk biomarkers for multiple cancers and providing invaluable insights into the complexities of immuno-oncology.
Draw biological conclusions. Faster.
Olink Insight empowers you on the journey from experiment planning and study design to post-run data analysis – in a single free online bioinformatic app.
Browse all publications
Olink is one of the world’s most trusted next-generation proteomics platforms, with over 1,800 publications across every major disease area. Our technology uncovers the truth of real-time biology for innovative startups, small research labs, and leading institutions and pharma companies.